ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Market Movers(Regular)

View all
NasdaqNYSEAMEXOTCTSXEuronextLSE

NASDAQ Market Status

Advancing
2,600(65.99%)
Declining
1,306(33.15%)
Unchanged
34(0.86%)
  • % Gainers
  • % Losers
  • Most Active
TickerNamePriceChangeChange %Volume
AVTX LogoAVTXAvalo Therapeutics Inc23.0918.34386.11%16,931,540
XLO LogoXLOXilio Therapeutics Inc1.69071.05164.59%23,721,136
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.830.971113.04%66,368,185
PIK LogoPIKKidpik Corporation4.501.2337.61%8,299,512
APAC LogoAPACStoneBridge Acquisition Corporation9.29992.4335.37%38,524
PEGRU LogoPEGRUProject Energy Reimagined Acquisition Corporation14.333.7134.93%6,006
OTRK LogoOTRKOntrak Inc0.80130.206334.67%21,954,226
CERO LogoCEROCERo Therapeutics Holdings Inc2.190.5634.36%1,169,482
PEGR LogoPEGRProject Energy Reimagined Acquisition Corporation11.502.8432.79%31,091
HUBCW LogoHUBCWHub Cyber Security Ltd0.01790.004129.71%600
MESO LogoMESOMesoblast Limited4.420.9326.65%5,604,830
PMEC LogoPMECPrimech Holdings Ltd1.8405-2.04-52.56%2,710,094
NBSTW LogoNBSTWNewbury Street Acquisition Corporation0.042279-0.02622-38.28%1,750
GMDA LogoGMDAGamida Cell Ltd0.0415-0.0177-29.90%39,827,033
UGRO LogoUGROUrban Gro Inc1.35-0.465-25.62%337,097
KOD LogoKODKodiak Sciences Inc5.64-1.81-24.30%950,516
DTST LogoDTSTData Storage Corporation5.8487-1.79-23.45%502,832
TNXP LogoTNXPTonix Pharmaceuticals Holding Corporation0.263-0.0639-19.55%7,485,882
MLKN LogoMLKNMillerKnoll Inc25.315-5.22-17.08%1,431,705
SEZL LogoSEZLSezzle Inc78.055-14.45-15.62%62,730
NCNA LogoNCNANuCana PLC0.2616-0.04505-14.69%802,682
SSKN LogoSSKNStrata Skin Sciences Inc0.382-0.0629-14.14%85,767
NKLA LogoNKLANikola Corporation1.010.100911.10%97,987,905
BDRX LogoBDRXBiodexa Pharmaceuticals PLC1.830.971113.04%66,368,185
AKAN LogoAKANAkanda Corporation0.19110.026215.89%54,776,964
MARA LogoMARAMarathon Digital Holdings Inc23.79191.727.80%41,839,396
GMDA LogoGMDAGamida Cell Ltd0.0415-0.0177-29.90%39,827,033
CISS LogoCISSC3is Inc0.0335-0.0047-12.30%39,512,540
AKBA LogoAKBAAkebia Therapeutics Inc1.995-0.245-10.94%36,305,868
TSLA LogoTSLATesla Inc176.834-3.00-1.67%33,552,984
SQQQ LogoSQQQProShares UltraPro Short QQQ10.4240.0240.23%29,787,839
AMD LogoAMDAdvanced Micro Devices Inc181.3681.780.99%26,726,719
KTRA LogoKTRAKintara Therapeutics Inc0.10350.01415.64%26,342,489
TradesView all

Big Movers

11:00
Business Wire

Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.

12:30
PR Newswire (US)

SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.

12:02
Business Wire

Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.

10:30
PR Newswire (US)

Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively recruiting  Phase 1b study of KSI-101 planned for 2Q2024 with the goal of initiating dual pivotal studies in 2024  New Phase 3 DAYBREAK study in wet AMD to include KSI-501 and tarcocimab investigational groups versus aflibercept targeted to start recruitment mid-2024 following completion of FDA discussions  Investor day to be scheduled after on-going regulatory interactions completedPALO ALTO, Calif., March 28, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and ...

Ticker Buzz Cloud
What is the Buzz Cloud?
  • The Buzz Cloud keeps track of how often tickers are mentioned to indicate the "level of buzz".
  • The larger the text, the more often the ticker is mentioned by the community.
  • You can use this page to spot trading opportunities based on the increase or decrease in the level of buzz.

Unlock more advanced trading tools

Join ADVFN today

Top Cryptocurrencies

View All Cryptos
Crypto Market Status
Advancing
8952(33%)
Declining
2890(10%)
Unchanged
14506(57%)
Ticker Name Price Change Change % Market Cap Volume
BTCBitcoin71,187.761,723.192.48%1.4T7,581,295,332
ETHEthereum3,578.0477.982.23%431.03B3,898,383,195
USDTTether USD1.000.000560.06%97.84B1,033,665,059
BNBBinance Coin583.389.251.61%92.44B514,650,269
SOLSolana186.10-0.020-0.01%82.48B1,683,514,224
STETHstETH3,568.64104.213.01%35.07B13,012,474
XRPRipple0.6230.01151.88%33.91B562,150,306
DOGEDogecoin0.215920.0258813.62%30.81B2,845,453,404
USDCUSD Coin1.000.000.00%28.07B1,433,361,766
ADACardano0.6540.00620.96%22.97B191,258,307

Economic Calendar

This week's major US economic reports, Fed Speakers, indicators and market-moving events.
View full calendar